Michael Kenison
Corporate Officer/Principal en PROTO LABS, INC. .
Fortuna: 702 268 $ al 30/04/2024
Perfil
Michael R.
Kenison is currently the Vice President & General Manager-Americas at Proto Labs, Inc. He previously worked as the Vice President-Manufacturing at Cardiac Science, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PROTO LABS, INC.
0.09% | 20/05/2024 | 22 351 ( 0.09% ) | 702 268 $ | 30/04/2024 |
Cargos activos de Michael Kenison
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTO LABS, INC. | Corporate Officer/Principal | 01/06/2021 |
Antiguos cargos conocidos de Michael Kenison.
| Empresas | Cargo | Fin |
|---|---|---|
Cardiac Science, Inc.
 Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PROTO LABS, INC. | Process Industries |
| Empresas privadas | 1 |
|---|---|
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Kenison
